The Food and Drug Administration (FDA) in December 2018 cleared for marketing a prescription smartphone application to help individuals being treated for opioid use disorder (OUD) stay in treatment and maintain their motivation to recover.
Modeled on an app cleared by the FDA in 2017 for patients with alcohol, cocaine, marijuana, and stimulant substance use disorders, reSET-O is specifically tailored for patients with OUD. The reSET-O app is intended for use in combination with outpatient psychosocial treatment that also includes treatment with buprenorphine. The app is downloaded directly to a patient’s smartphone after the patient receives a prescription to do so from his or her physician.
Published Online:24 Jan 2019
Author: Mark Moran